These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4374338)

  • 21. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
    Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
    J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spermatogenesis in men treated with injections of medroxyprogesterone acetate combined with testosterone enanthate.
    Frick J; Danner C; Kunit G; Joos H; Köhle R
    Int J Androl; 1982 Jun; 5(3):246-52. PubMed ID: 7118265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Administration of norethandrolone and testosterone as a contraceptive agent for men.
    Brenner PF; Bernstein GS; Roy S; Jecht EW; Mishell DR
    Contraception; 1975 Feb; 11(2):193-207. PubMed ID: 1112088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oligozoospermia induced by exogenous testosterone is associated with normal functioning residual spermatozoa.
    Wang C; Leung A; Superlano L; Steiner B; Swerdloff RS
    Fertil Steril; 1997 Jul; 68(1):149-53. PubMed ID: 9207601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
    Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
    Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
    Bremner WJ; Bagatell CJ; Steiner RA
    J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of monthly depot medroxyprogesterone acetate and testosterone on human spermatogenesis. I. Uniform dosage levels.
    Frick J; Bartsch G; Weiske WH
    Contraception; 1977 Jun; 15(6):649-68. PubMed ID: 891192
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies with cyproterone acetate for male contraception.
    Roy S; Chatterjee S
    J Steroid Biochem; 1979 Jul; 11(1B):675-80. PubMed ID: 491632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential for an androgen male contraceptive.
    Cunningham GR; Silverman VE; Thornby J; Kohler PO
    J Clin Endocrinol Metab; 1979 Oct; 49(4):520-6. PubMed ID: 479345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison between testosterone oenanthate-induced azoospermia and oligozoospermia in a male contraceptive study. IV. Suppression of endogenous testicular and adrenal androgens.
    Anderson RA; Wallace AM; Kicman AT; Wu FC
    Hum Reprod; 1997 Aug; 12(8):1657-62. PubMed ID: 9308789
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of testosterone enanthate on testis size.
    Palacios A; McClure RD; Campfield A; Swerdloff RS
    J Urol; 1981 Jul; 126(1):46-8. PubMed ID: 6788960
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endocrinological and physiological features after steroid treatment of male rats.
    Hunt DM; Lau IF; Saksena SK; Chang MC
    Arch Androl; 1978 Sep; 1(4):311-20. PubMed ID: 736678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in research into new methods of fertility regulation for men.
    Prog Hum Reprod Res; 1995; (33):2. PubMed ID: 12289975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
    Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: Reversible contraceptive action of testosterone in males.
    Reddy PR
    J Reprod Fertil; 1974 May; 38(1):232. PubMed ID: 4842314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolactin injection, a new contraceptive method: experimental study.
    Shafik A
    Contraception; 1994 Aug; 50(2):191-9. PubMed ID: 7956218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
    Kamischke A; Venherm S; Plöger D; von Eckardstein S; Nieschlag E
    J Clin Endocrinol Metab; 2001 Jan; 86(1):303-9. PubMed ID: 11232016
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of norethisterone and estradiol in mini doses as a contraceptive in the male. Efficacy studies in the adult male bonnet monkey (Macaca radiata).
    Shetty G; Krishnamurthy H; Krishnamurthy HN; Ramachandra SG; Moudgal NR
    Contraception; 1997 Oct; 56(4):257-65. PubMed ID: 9408708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of spermatogenesis in man induced by Nal-Glu gonadotropin releasing hormone antagonist and testosterone enanthate (TE) is maintained by TE alone.
    Swerdloff RS; Bagatell CJ; Wang C; Anawalt BD; Berman N; Steiner B; Bremner WJ
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3527-33. PubMed ID: 9768659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of 19-nortestosterone-hexyloxyphenylpropionate (Anadur) and depot-medroxyprogesterone-acetate (Clinovir) for male contraception.
    Knuth UA; Yeung CH; Nieschlag E
    Fertil Steril; 1989 Jun; 51(6):1011-8. PubMed ID: 2524404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.